Stay updated on Pembrolizumab Combo Clinical Trial in Advanced NSCLC
Sign up to get notified when there's something new on the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page.

Latest updates to the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page
- Check7 days agoChange DetectedThe ClinicalTrials.gov page footer now displays software revision v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check14 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedOn the Study Record History page, the UI now shows 'Find contact information' and the revision stamp updated to 'Revision: v3.7.0', replacing the previous 'Find Contact Information' and 'Revision: v3.6.6'.SummaryDifference0.1%

- Check57 days agoChange DetectedThe update adds the new Study Status and Contacts/Locations sections to the study history, providing current status and contact details. The page revision has been bumped to v3.6.6 to reflect this update.SummaryDifference0.2%

- Check78 days agoChange DetectedRevision: v3.6.5 appears in the page footer, replacing Revision: v3.6.4. This marks a new page build.SummaryDifference0.0%

- Check85 days agoChange DetectedNew entries for versions 87 and 88 were added to the study record history, including the addition of the Contacts/Locations and Study Status sections around 2026-07-30, and a prior history entry from 2026-06-23 was deleted.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab Combo Clinical Trial in Advanced NSCLC
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page.